CS

Candriam SCA Portfolio holdings

AUM $17.3B
1-Year Est. Return 21.68%
This Quarter Est. Return
1 Year Est. Return
+21.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.46B
AUM Growth
+$433M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
907
New
Increased
Reduced
Closed

Top Buys

1
+$59.9M
2
+$49.9M
3
+$49.5M
4
JD icon
JD.com
JD
+$44.8M
5
TMO icon
Thermo Fisher Scientific
TMO
+$40.8M

Top Sells

1
+$114M
2
+$102M
3
+$58.9M
4
BMY icon
Bristol-Myers Squibb
BMY
+$58.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$52M

Sector Composition

1 Healthcare 34.68%
2 Technology 20.98%
3 Consumer Discretionary 8.92%
4 Financials 8.6%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
801
– –
-2,676
802
– –
-27,680
803
– –
-111
804
– –
-13,000
805
– –
-75,497
806
– –
-80,887
807
– –
-2,582
808
– –
-54,208
809
– –
-5,468
810
– –
-3,718
811
– –
-2,090
812
– –
-18,700
813
– –
-15,038
814
– –
-30,126
815
– –
-411,991
816
– –
-82,200
817
– –
-7,020
818
– –
-24,500
819
– –
-46
820
– –
-44,790
821
– –
-31,000
822
– –
-121,500
823
– –
-256,392
824
– –
-1,935
825
– –
-43,643
31 32
33
34 35